BeiGene clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   BGB-11417 · Mature B-cell Malignancies

   Trial completed

   BeiGene·Phase 1· NCT04883957· Registry history of NCT04883957 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

2. Minor

   Different Doses of BG-68501 Given to · Advanced-Stage Tumors

   Study completion pushed from Aug 31, 2026 to Aug 27, 2027

   BeiGene·Phase 1· NCT06257264· Registry history of NCT06257264 on ClinicalTrials.gov (opens the registry)

   Oct 20, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.